April 7, 2026 – 6:00 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry ...
PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, today made the following announcement regarding the financial calendar: Due to administrative ...
No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at Coca-Cola Europacific Partners is one of the ...
April 2026 - 6.00 pm - Lhyfe (Euronext Paris - FR0014009YQ1 - LHYFE), an independent green hydrogen producer for low carbon industry and mobility, informs to the total number of shares and voting ...
Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma ...
KLEA HOLDING - Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals ...
CAPITAL B - Capital B announces the tokenization of existing ALCPB shares on Liquid via the Bitcoin-native solution of the STOKR platform ...
CBo Territoria is pleased to announce that the annual financial report as of December 31, 2025 have been made available to the public and filed with the French Financial Markets Authority, in ESEF ...
In 2025, the AKWEL Group reported consolidated revenue of €938.3 million, down 5.1% and 4.1% on a like-for-like basis and at constant exchange rates. This decline in activity was similar across EMEA ( ...
The GTS business, reported separately since 1 January 2025, is growing strongly, with a doubling of activity over the year (+103.9%), driven by the integration of Blastcon Australia and the strong ...
LHYFE - 2025 Annual results Lhyfe continues its growth and doubles revenues in 2025 - A sovereign player, Europe's largest RFNBO hydrogen producer ...
SEIF S.p.A - The Board of Directors approves the draft annual financial statements and the consolidated financial statements as at 31 December 2025 ...